Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1046830

registered interest
date	23/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) detect and diagnose lung disease earlier and (b) support people with chronic respiratory conditions to manage their health.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	211682
answer	answer is ministerial correction date of answer 28/01/2019 answer text <p>The Government is committed to improving the lives of those with respiratory disease.</p><p>Respiratory disease is a clinical priority within the recently published NHS Long Term Plan. This has the overarching objective of improving outcomes for people with respiratory disease. The Long Term Plan sets out how the National Health Service will take action in a number of areas. This includes expanding programmes that support earlier diagnosis of respiratory disease including the pioneering lung health checks trialled in Manchester and Liverpool; increasing access to proven treatments such as pulmonary rehabilitation (a structured exercise and education programme for those with chronic respiratory disease and breathlessness); and improving support for those with chronic respiratory diseases such as asthma to receive and use the correct medications.</p><p>The NHS Long Term Plan will build on a range of existing national initiatives focussed on the diagnosis and treatment of respiratory disease, some of which are detailed below.</p><p>The NHS Outcomes Framework sets out the Department’s priority areas for the NHS, and includes reducing deaths from respiratory disease as a key indicator.</p><p>The National Institute for Health and Care Excellence (NICE) publishes quality standards that define best practice and areas in need of improvement for a range of respiratory illnesses including chronic obstructive pulmonary disease (COPD), asthma and idiopathic pulmonary fibrosis, with the aim of raising the standard of care that people with these conditions receive. NICE quality standards cover both diagnosis and treatment.</p><p>The NHS RightCare COPD pathway is being rolled out nationally through clinical commissioning groups and defines the core components of an optimal service for people with COPD. This includes timely access to pulmonary rehabilitation as part of the optimal treatment pathway.</p><p>The Department and NHS England are supportive of the National Asthma and COPD Audit Programme. Launched in March 2018 and led by the Royal College of Physicians, this programme aims to improve quality of care, services, and clinical outcomes for patients with asthma and COPD by collecting and providing data on a range of indicators.</p><p>Furthermore, NHS England commissions treatments for rare or complex respiratory conditions through the Specialised Respiratory Clinical Reference Group, which is chaired by Professor Mike Morgan. This includes specialist treatment for pulmonary hypertension, idiopathic pulmonary fibrosis and severe asthma among other conditions.</p><p>The Department also funds research on respiratory illnesses through the National Institute for Health Research.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/01/2019 17:16:04 answering member 4067 label Biography information for Steve Brine
tabling member	1436 label Biography information for Paul Farrelly

1046835

registered interest
date	23/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding will be allocated to the respiratory programme set out in the NHS Long Term Plan.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	211683
answer	answer is ministerial correction date of answer 28/01/2019 answer text <p>NHS England is not able to release exact figures at present.</p><p>The National Implementation Framework, to be published in the spring, will provide further information on how the Long Term Plan will be implemented. Further details, based on local health system five year plans, will be brought together in a detailed national implementation plan in the autumn.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/01/2019 17:14:13 answering member 4067 label Biography information for Steve Brine
tabling member	1436 label Biography information for Paul Farrelly

1043054

registered interest
date	17/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to his oral contribution of 7 January 2019, Official Report column 80, when he plans to publish the local provision funding increases for the first year of the NHS Long Term Plan.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	209758
answer	answer is ministerial correction date of answer 22/01/2019 answer text <p>NHS England set clinical commissioning group (CCG) allocations. The National Health Service published draft five-year CCG allocations for 2019/20 to 2023/24 on 10 January 2019 at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/draft-ccg-allocations-2019-20-to-2023-24-core-services/" target="_blank">https://www.england.nhs.uk/publication/draft-ccg-allocations-2019-20-to-2023-24-core-services/</a></p><p> </p><p>These are subject to final approval by the NHS England Board on 31 January 2019.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 22/01/2019 17:04:07 answering member 1585 label Biography information for Stephen Hammond
tabling member	1436 label Biography information for Paul Farrelly

1039590

registered interest
date	11/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to involve people with learning disabilities and autism in the development of mandatory training for NHS staff.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	207559
answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>We will shortly consult on proposals for mandatory learning disability and autism training to ensure that staff working in health and social care understand the needs of people with learning disabilities and autism and have the skills to provide them with the most effective care and support. Officials have worked with people with lived experience of learning disabilities and autism to develop the consultation proposals.</p><p> </p><p>We want to hear a range of views, including those from people with a learning disability or autism and their families, and in line with Cabinet Office principles on consultation, we will tailor the consultation to meet the needs and preferences of different groups, including the provision of consultation documents in alternative formats.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 16/01/2019 12:21:26 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1436 label Biography information for Paul Farrelly

1035008

registered interest
date	04/01/2019
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Foster Care: Care Leavers
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, what assessment his Department has made of implications for his policies of the recommendation in the Staying put: an unfulfilled promise, published by the Fostering Network in November 2018.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	205212
answer	answer is ministerial correction date of answer 14/01/2019 answer text <p>‘Staying Put’ has helped thousands of care leavers to transition more smoothly from care to living independently. It provides continuity of relationships and care arrangements, enabling care leavers to benefit from a stable and secure family setting, and to prepare for independence at a more gradual pace, rather than facing a ‘cliff-edge’ at age 18.</p><p>The government keeps the Staying Put policy under constant review, including through monitoring data from local authorities on take-up by young people, engagement with the sector, and reviewing information from Ofsted inspections of local authorities. Staying Put was also considered as part of the independent fostering review undertaken by Sir Martin Narey and Mark Owers, published in February 2018.</p><p>The latest data show that increasing numbers of care leavers are living in Staying Put arrangements. In the year ending March 2018, 55% of 18-year-olds chose to Stay Put, which is an increase of 4% on 2017. Furthermore, the data show that 31% of 19-year-olds, and 26% of 20-year-olds were still living with their former foster carers, which represent increases on the previous year.</p><p>In 2018 to 2019 the government provided £23.3 million to local authorities to implement Staying Put, with a further £23.77 million committed for 2019 to 2020. Decisions on funding beyond March 2020 will be subject to the outcome of the next Spending Review.</p><p>The government does not believe that introducing a national minimum allowance for Staying Put carers is the right way forward. Unlike children in foster care, young people in Staying Put arrangements are adults, and may be in work or claiming benefits. These financial sources can be used to contribute to the cost of providing the Staying Put arrangement, in a similar way that young people who are still living at home with their parents may contribute to the costs of running the household.</p><p>The government does not believe a foster carer’s approval should automatically lapse after 12 months if they are a Staying Put carer. We will communicate this message to the sector.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/01/2019 17:48:00 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1436 label Biography information for Paul Farrelly

1024789

registered interest
date	13/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer: Staffordshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) increase early diagnosis rates for ovarian cancer and (b) increase access to treatment for ovarian cancer in specialist centres in Staffordshire.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	202081
answer	answer is ministerial correction date of answer 18/12/2018 answer text <p>Public Health England (PHE) has run a number of ‘Be Clear on Cancer’ campaigns to help improve early detection of cancer including ovarian cancer. In 2014 PHE ran a pilot regional ovarian cancer campaign in the North West of England. In 2017, PHE ran a pilot campaign in the East and West Midlands which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of a number of cancers, including ovarian cancer. NHS England has invested over £200 million between 2017 and 2019, supporting Cancer Alliances to accelerate diagnosis and enhance quality of life.</p><p> </p><p>Staffordshire clinical commissioning groups commission diagnostic services for ovarian cancer fully in line with National Institute for Health and Care Excellence guidelines across the whole sustainability and transformation partnership.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/12/2018 17:04:54 answering member 4067 label Biography information for Steve Brine
tabling member	1436 label Biography information for Paul Farrelly

1022956

registered interest
date	10/12/2018
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Children: Social Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, what recent assessment he has made of the correlation between deprivation and demand for children’s services.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	200581
answer	answer is ministerial correction date of answer 13/12/2018 answer text <p>Demand for children’s services is associated with a number of factors, including deprivation. The most deprived local authorities (LAs) have more looked after children (per 10,000 17 year olds), and these rates have grown faster than the least deprived LAs.</p><p>In preparation for the Spending Review, to help ensure decisions are based on the best available evidence, the government is working with the sector to develop a sharper and more granular picture of demand for children’s services.</p><p>We are also working with Ministry of Housing, Communities and Local Government as part of the Government’s Fair Funding Review of relative needs and resources, where new, up-to-date formulas are being developed to ensure funding distribution to councils is based on the best available evidence.</p><p>We welcome the contributions from the sector in this area, including Newton Europe’s Making Sense (2018) report and the Association of Directors of Children’s Services' continuing research reports, Safeguarding Pressures (2018).</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/12/2018 14:41:48 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1436 label Biography information for Paul Farrelly

1020404

registered interest
date	05/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medicines and Healthcare products Regulatory Agency
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA), and with reference to the transition period set out in the Agreement on the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, if the MHRA will be recognised as an EU competent authority under the EU (a) Medical Devices Directive, (b) in-vitro diagnostic medical devices, and (c) Medical Devices Regulation during the period covered by the Agreement.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	199325
answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as a European Union competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p> </p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p> </p><p>It is possible for a single organisation to have individual notified bodies designated in more than one Member State. The authority within each Member State is responsible for notified bodies based in its own country.</p><p> </p><p>The MHRA is responsible for the designation and monitoring of notified bodies in the United Kingdom, which the response to Question 196736 refers to.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 199327 question first answered 10/12/2018 14:12:25 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly

1020405

registered interest
date	05/12/2018
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	Medicines and Healthcare products Regulatory Agency
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA) and with reference to the transition period set out in the Agreement on the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, if the MHRA will be recognised as an EU competent authority under EU Regulations (a) Medical Devices Directive, (b) in-vitro diagnostic medical devices, and (c) Medical Devices Regulation during that period.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	199326
answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as an EU competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p><strong></strong><br><br></p><p> </p> answering member constituency Daventry answering member printed Chris Heaton-Harris question first answered 10/12/2018 15:48:34 answering member 3977 label Biography information for Chris Heaton-Harris
tabling member	1436 label Biography information for Paul Farrelly

1020408

registered interest
date	05/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment: UK Notified Bodies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA), whether the Department's response refers to (a) UK notified bodies licensed by the MHRA and (b) UK notified bodies that have also secured notified body status in other EU states.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	199327
answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as a European Union competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p> </p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p> </p><p>It is possible for a single organisation to have individual notified bodies designated in more than one Member State. The authority within each Member State is responsible for notified bodies based in its own country.</p><p> </p><p>The MHRA is responsible for the designation and monitoring of notified bodies in the United Kingdom, which the response to Question 196736 refers to.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 199325 question first answered 10/12/2018 14:12:25 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly